Match Document Document Title
7414064 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives  
Compounds of formula wherein A 1 , A 2 and A 3 are each independently of the others a bond or a C 1 -C 6 alkylene bridge; A 4 is a C 1 -C 6 alkylene bridge; D is CH or N; W is, for...
7414060 Pyridine-2-carboxyamide derivatives  
The invention relates to compounds of formula I: wherein R 1 to R 3 are as defined in the specification, to processes for their preparation, to pharmaceutical compositions containing them,...
7399775 β-amyloid protein production/secretion inhibitor  
Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1): and capable of...
7396936 Modulators of calcitonin and amylin receptor activity  
In various aspects, the present invention relates to non-peptidic compounds, which modulate calcitonin and amylin receptor activity; to processes for the preparation of some such compounds; and to...
7396840 Chemokine receptor binding heterocyclic compounds  
Tertiary amine compounds that bind chemokine receptors such as CXCR4 and CCR5 are disclosed.
7393865 Sleep inducing compounds and methods relating thereto  
Compounds having the following structure (I): including stereoisomers, prodrugs, and pharmaceutically acceptable salts, esters and solvates thereof, wherein R 1 , R 2 , R 3a , R 3b , L 1 , L 2 ...
7384961 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants  
Saturated and unsaturated heteroarylcycloalkylmethyl-amine compounds corresponding to formula I, processes for their preparation, pharmaceutical formulations comprising these compounds and the...
7375122 Compounds useful as pesticides  
Compounds useful to control pests are provided.
7375118 Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation  
The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic....
7365068 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication  
The invention provides compounds and pharmaceutically acceptable salts of Formula I wherein the variables A 1 , A 2 , R 1 , R 2 , V, W, X, Y, and Z are defined herein. Certain compounds of...
7361658 2-acylaminothiazole derivative or salt thereof  
2-Acylaminothiazole derivatives or salts thereof which have a platelet increasing activity based on an excellent human c-mpl-Ba/F3 cell growth function and a function of accelerating formation of...
7354936 2-phenylpyran-4-one derivatives  
The present invention relates to 2-(4-sulphonylphenyl)pyran-4-one derivatives of general formula processes for their preparation, pharmaceutical compositions containing them, and their medical...
7351825 Cyclopropane compounds and pharmaceutical use thereof  
The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the...
RE40155 Methods for treatment of benign and malignant tumors, including lymphomas, leukemias, and leiomyomas  
In a preferred embodiment, drugs having chemotherapeutic properties which are useful against certain neoplastic disorders with wide safety margins as evidenced by their low toxicity, and molecular...
7332509 Heterocyclic amides, a process for their preparation, compositions comprising them and their use  
What is described are amides of the formula (I) and salts thereof, where the symbols and indices are as defined below: X is CH or N; Y is O or S; n is 0 or 1; R 1 is (C 1 -C 4...
7332504 Heterocyclic substituted aminoazacycles useful as central nervous system agents  
Heterocyclic substituted aminoazacyclic compounds of formula I Z-R 3 I, ...
7317010 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone  
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I), wherein: R 1 , R 2 , R 4 , R 5 , R 6 , R 6a , R 7 , R 8 , A and B are as defined in the specification, which are...
RE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation  
A compound having the following formula: wherein R 3 and M are defined herein, and processes therewith.
7312236 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT1F agonists  
The present invention relates to compounds of formula I: or a pharmaceutically acceptable acid addition salt thereof, where; X is —C(R 4 )═ or —N═; Ar is phenyl, substituted...
7312235 Benzamide inhibitors of factor Xa  
Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian Factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or...
7297694 Pyridylfurans and pyrroles as Raf kinase inhibitors  
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac...
7297693 Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors  
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac...
7291631 CXCR4 chemokine receptor binding compounds  
The present invention relates to compounds that bind to chemokine receptors, and having the formula wherein each A, X, Y, R 1 , R 2 and R 3 are substituents. The present invention also...
7282514 Reactive probes for two-photon fluorescent imaging and sensing  
Fluorescent dyes and probes are key components in multiphoton based fluorescence microscopy imaging of biological samples. In order to address the demand for better performing dyes for two-photon...
7282502 CCR9 inhibitors and methods of use thereof  
The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates...
7279476 Pyrazole-derived kinase inhibitors and uses thereof  
Described herein are compounds that are useful as protein kinase inhibitors having the formula: where B, R 1 , n, R 3 , Q, and R 4 are described in the specification. The compounds are useful...
7271181 Inhibitors of p38  
The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods...
7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators  
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being...
7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists  
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
7256203 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents  
A compound of Formula (I): wherein: X is selected from the group consisting of O, S, and NR 17 , where R 17 is hydrogen or lower alkyl; A and Y are CH, N, NR 17 , O, or S; C 1 and C 2 ...
7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry  
The invention relates to 2-thio-substituted imidazole derivatives of the formula I in which the radicals R 1 , R 2 , R 3 and R 4 are as defined in the description. The compounds according to...
7253188 Aminobenzamide derivative  
This invention relates to a novel compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein R 1 is —S(O)p-A, —S—(O)q-B or —O-D, wherein p...
7253187 Heterocyclic inhibitors of ERK2 and uses thereof  
Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein Z 1 and Z 2 are each independently nitrogen or CH and Ring A, T m R 1 , QR 2 , U n R 3...
7244763 Compounds that modulate PPAR activity and methods of preparation  
This invention relates to compounds that alter PPAR activity. The invention also relates to pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising...
7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors  
The present invention concerns the compounds having the formula N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R 1 and R 8 each are...
7241758 Compounds useful as anti-inflammatory agents  
Disclosed are novel aromatic compounds of the formula (I) wherein G, X, Ar, L and Q are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological...
7238717 CCR9 inhibitors and methods of use thereof  
The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates...
7230015 Method of treating of demyelinating diseases or conditions  
N-(Pyridinyl)-1H-indol-1-amines of formula I provide a unique combination of blocking properties for both the potassium and sodium channels. These compounds are useful for the treatment of...
7217714 CCR5 modulators  
Compounds of Formula 1 [R egion α]−[R egion β]−[R egion γ]−[R egion δ] (I)
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7211595 Farnesyltransferase inhibitors  
Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting...
7205305 Inhibitors of p38  
The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods...
7196106 Cyanothiophene derivatives, compositions containing such compounds and methods of use  
The present invention addresses substituted cyanothiophene derivatives of the formula I: as well as compositions containing such compounds and methods of treatment. The compounds in the present...
7196102 Calcium receptor modulating agents  
The compounds of the invention are represented by the following general structure or a pharmaceutically acceptable salt thereof, and compositions containing them, wherein the variables are...
7196100 Opioid receptor antagonists  
A compound of the formula (I) wherein the variables X 1 to X 5 , R 1 to R 7 including R 3′ , E, q, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate,...
7196089 EP4 receptor antagonists  
Compounds of formula (I): wherein: R 2 is H or an optionally substituted C 1-4 alkyl group; Y is either —(CH 2 ) n —X—, where n is 1 or 2 and X is O, S, S(═O), S(═O) 2 , or NR N1 ,...
7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents  
The invention relates to new pyridylalkane, alkene, and alkine carboxamides substituted with an imide with a saturated or one or several-fold unsaturated hydrocarbon residue in the carboxylic acid...
7189755 Pyrrolidine melanocortin-specific compounds  
Melanocortin receptor-specific pyrrolidine compounds having the structure: and stereoisomer and pharmaceutically acceptable salts thereof, where R 1 , R 2 , and R 3 are as described in the...
7186719 Antibacterial agents  
Compounds of formula (II) are antibacterial agents wherein Q represents a radical of the formula: —N(OH)CH(═O) or the formula: —C(═O)NH(OH); R 1 represents hydrogen, C 1 –C 6 alkyl or C...
7186709 Dihydropyrancarboxamides and uses thereof  
The present invention provides novel dihydropyrancarboxamide compounds of formula (I): and collections of these compounds, and provides methods for the synthesis of these compounds; wherein R 1...